Niche London-based secondaries investor Headway Capital Partners has promoted three to partner.
Zoe Yeo and Ulrich Hardt, who both joined the firm in 2009, have been promoted from investment director, a statement said. Yeo joined Headway from Dresdner Kleinwort with Hardt previously holding roles at 3i and Calyon Credit Agricole CIB.
US-based Cliff Meijer has also been promoted. Meijer joined Headway as managing director in 2015 and helps to lead business development in the US as well as investment execution. He was previously managing partner of the private equity fund management practice at investment bank Thomas Weisel Partners and subsequently Stifel Financial.
The promotion follows that of Jason Howard earlier this year, who took on the additional role of COO alongside his CFO role. Howard joined in 2018 from EQT.
Headway invests in co-investments and secondaries transactions. It focuses on small-to- mid-sized independent sponsors through GP-led and secondary direct transactions in Europe and North America.
The firm is currently deploying its 2018-vintage Headway Investment Partners IV, which closed on €372 million in 2019. Headway’s investment team has grown by approximately 50 percent since the beginning of 2018, a spokesperson said.
Recent investments include a single-asset continuation fund centred on the molecular diagnostics and anatomic pathology businesses of Vitro Group. Spain-headquartered GED Capital is the manager.
In January, Headway also made a co-investment alongside healthcare-focused private equity firm Harbour Point Capital in ambulance services provider Midwest Medical Transport.
Headway was founded in 2004 by former Coller Capital investment professionals Sebastian Junoy, Christiaan de Lint and Laura Shen.